Pharma-Bio Serv, Inc. (PBSV)
USD 0.38
(-21.86%)
USD 0.38
(-21.86%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 5.06 Million USD | 3.79% |
| 2022 | 4.88 Million USD | -8.93% |
| 2021 | 5.35 Million USD | -19.6% |
| 2020 | 6.66 Million USD | 7.93% |
| 2019 | 6.17 Million USD | 8.61% |
| 2018 | 5.68 Million USD | 57.48% |
| 2017 | 3.61 Million USD | -37.56% |
| 2016 | 5.78 Million USD | -22.73% |
| 2015 | 7.48 Million USD | -16.59% |
| 2014 | 8.97 Million USD | -24.17% |
| 2013 | 11.83 Million USD | 19.87% |
| 2012 | 9.87 Million USD | 43.88% |
| 2011 | 6.86 Million USD | 102.22% |
| 2010 | 3.39 Million USD | -11.62% |
| 2009 | 3.83 Million USD | -33.7% |
| 2008 | 5.78 Million USD | -15.15% |
| 2007 | 6.82 Million USD | 11.62% |
| 2006 | 6.11 Million USD | 61036.24% |
| 2005 | 10 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 618.47 Thousand USD | 15.47% |
| 2024 Q3 | 635.38 Thousand USD | 2.73% |
| 2024 Q1 | 535.6 Thousand USD | -42.4% |
| 2023 Q1 | 1.24 Million USD | 11.86% |
| 2023 Q4 | 929.8 Thousand USD | -40.01% |
| 2023 Q3 | 1.55 Million USD | 15.12% |
| 2023 FY | 5.06 Million USD | 3.79% |
| 2023 Q2 | 1.34 Million USD | 8.57% |
| 2022 FY | 4.88 Million USD | -8.93% |
| 2022 Q3 | 1.31 Million USD | 7.93% |
| 2022 Q2 | 1.21 Million USD | -2.3% |
| 2022 Q1 | 1.24 Million USD | -16.97% |
| 2022 Q4 | 1.1 Million USD | -15.52% |
| 2021 Q2 | 1.29 Million USD | -1.84% |
| 2021 FY | 5.35 Million USD | -19.6% |
| 2021 Q1 | 1.31 Million USD | -3.14% |
| 2021 Q3 | 1.25 Million USD | -2.77% |
| 2021 Q4 | 1.49 Million USD | 19.43% |
| 2020 Q4 | 1.35 Million USD | -26.78% |
| 2020 Q1 | 1.58 Million USD | 3.1% |
| 2020 FY | 6.66 Million USD | 7.93% |
| 2020 Q2 | 1.86 Million USD | 17.85% |
| 2020 Q3 | 1.85 Million USD | -0.79% |
| 2019 FY | 6.17 Million USD | 8.61% |
| 2019 Q4 | 1.53 Million USD | -1.77% |
| 2019 Q1 | 1.47 Million USD | -25.61% |
| 2019 Q2 | 1.59 Million USD | 7.73% |
| 2019 Q3 | 1.56 Million USD | -1.72% |
| 2018 Q4 | 1.98 Million USD | 23.63% |
| 2018 Q3 | 1.6 Million USD | 59.67% |
| 2018 Q2 | 1 Million USD | -7.01% |
| 2018 Q1 | 1.08 Million USD | 77.71% |
| 2018 FY | 5.68 Million USD | 57.48% |
| 2017 Q4 | 609.48 Thousand USD | -34.33% |
| 2017 Q3 | 928.11 Thousand USD | -10.86% |
| 2017 Q2 | 1.04 Million USD | 0.86% |
| 2017 Q1 | 1.03 Million USD | -3.95% |
| 2017 FY | 3.61 Million USD | -37.56% |
| 2016 Q3 | 1.42 Million USD | -6.45% |
| 2016 Q4 | 1.07 Million USD | -24.62% |
| 2016 Q1 | 1.75 Million USD | -14.09% |
| 2016 Q2 | 1.52 Million USD | -13.32% |
| 2016 FY | 5.78 Million USD | -22.73% |
| 2015 Q1 | 1.7 Million USD | -26.9% |
| 2015 FY | 7.48 Million USD | -16.59% |
| 2015 Q4 | 2.04 Million USD | 0.03% |
| 2015 Q3 | 2.04 Million USD | 21.36% |
| 2015 Q2 | 1.68 Million USD | -1.13% |
| 2014 Q3 | 2.17 Million USD | 4.23% |
| 2014 Q4 | 2.33 Million USD | 7.1% |
| 2014 Q1 | 2.37 Million USD | -25.05% |
| 2014 FY | 8.97 Million USD | -24.17% |
| 2014 Q2 | 2.08 Million USD | -11.9% |
| 2013 Q4 | 3.16 Million USD | 6.21% |
| 2013 FY | 11.83 Million USD | 19.87% |
| 2013 Q3 | 2.98 Million USD | -4.54% |
| 2013 Q2 | 3.12 Million USD | 21.62% |
| 2013 Q1 | 2.56 Million USD | -2.41% |
| 2012 FY | 9.87 Million USD | 43.88% |
| 2012 Q4 | 2.63 Million USD | 1.2% |
| 2012 Q3 | 2.59 Million USD | 8.46% |
| 2012 Q2 | 2.39 Million USD | 6.65% |
| 2012 Q1 | 2.24 Million USD | 4.96% |
| 2011 Q3 | 1.99 Million USD | 29.42% |
| 2011 Q4 | 2.14 Million USD | 7.05% |
| 2011 FY | 6.86 Million USD | 102.22% |
| 2011 Q1 | 1.17 Million USD | 18.03% |
| 2011 Q2 | 1.54 Million USD | 31.38% |
| 2010 FY | 3.39 Million USD | -11.62% |
| 2010 Q2 | 756.74 Thousand USD | 0.74% |
| 2010 Q4 | 996.38 Thousand USD | 12.14% |
| 2010 Q3 | 888.49 Thousand USD | 17.41% |
| 2010 Q1 | 751.17 Thousand USD | -17.56% |
| 2009 Q2 | 1.19 Million USD | 38.76% |
| 2009 Q3 | 873.18 Thousand USD | -26.97% |
| 2009 Q4 | 911.12 Thousand USD | 4.35% |
| 2009 FY | 3.83 Million USD | -33.7% |
| 2009 Q1 | 861.73 Thousand USD | -39.56% |
| 2008 Q4 | 1.42 Million USD | -13.27% |
| 2008 Q2 | 1.35 Million USD | -0.34% |
| 2008 Q1 | 1.36 Million USD | -8.47% |
| 2008 FY | 5.78 Million USD | -15.15% |
| 2008 Q3 | 1.64 Million USD | 21.07% |
| 2007 FY | 6.82 Million USD | 11.62% |
| 2007 Q4 | 1.48 Million USD | -27.95% |
| 2007 Q3 | 2.06 Million USD | 13.62% |
| 2007 Q2 | 1.81 Million USD | 25.3% |
| 2007 Q1 | 1.45 Million USD | -18.81% |
| 2006 Q3 | 1.38 Million USD | -11.95% |
| 2006 Q4 | 1.78 Million USD | 29.18% |
| 2006 Q2 | 1.57 Million USD | 14.12% |
| 2006 FY | 6.11 Million USD | 61036.24% |
| 2006 Q1 | 1.37 Million USD | 0.0% |
| 2005 FY | 10 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Achiko AG | 23.34 Thousand USD | -21602.339% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 3.91 Million USD | -29.361% |
| Cannabis Sativa, Inc. | 773.08 Thousand USD | -555.351% |
| CompuMed, Inc. | 2.88 Million USD | -75.54% |
| CompuGroup Medical SE & Co. KGaA | 413.14 Million USD | 98.774% |
| Cogstate Limited | 24.7 Million USD | 79.493% |
| CareView Communications, Inc. | 6.53 Million USD | 22.425% |
| Craneware plc | 162.19 Million USD | 96.876% |
| Caduceus Software Systems Corp. | 925.07 Thousand USD | -447.676% |
| Certive Solutions Inc. | 137.87 Thousand USD | -3574.694% |
| Drug Free Solution, Inc. | 805.00 USD | -629267.826% |
| DATATRAK International, Inc. | 5.14 Million USD | 1.574% |
| Strainsforpains, Inc. | 84.11 Thousand USD | -5923.124% |
| Healixa Inc. | 210.81 Thousand USD | -2303.307% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 12.3 Million USD | 58.82% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 82.05 Thousand USD | -6074.634% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | -298.05 USD | 1699952.709% |
| IQ-AI Limited | 614.03 Thousand USD | -725.101% |
| Cannabiz Mobile, Inc. | - USD | -Infinity% |
| Mednow Inc. | -858.82 Thousand USD | 689.926% |
| Galileo Life Sciences, Inc. | - USD | -Infinity% |
| MediXall Group, Inc. | -3.13 Million USD | 261.404% |
| Mitesco, Inc. | - USD | -Infinity% |
| MobileSmith, Inc. | 821.2 Thousand USD | -516.952% |
| NantHealth, Inc. | 38.16 Million USD | 86.724% |
| Net Medical Xpress Solutions, Inc. | -60 Thousand USD | 8544.018% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 222.9 Thousand USD | -2172.952% |
| Patient Access Solutions, Inc. | 212.73 Thousand USD | -2281.548% |
| PPJ Healthcare Enterprises, Inc. | 216.06 Thousand USD | -2244.844% |
| Medical Cannabis Payment Solutions, Inc. | -21.91 Thousand USD | 23216.353% |
| Renalytix Plc | 156 Thousand USD | -3147.699% |
| Revium Recovery Inc. | -2000.00 USD | 253420.55% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 396.65 Thousand USD | -1177.3% |
| Vaso Corporation | 50.59 Million USD | 89.986% |
| Vynleads, Inc. | -35.57 Thousand USD | 14343.495% |